SCHEMBL31700714

SCHEMBL31700714

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(-c3cnn(CC4CCNCC4)c3)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 6/20 0.52
▸ CRBN Q96SW2 6/20 0.52
▸ PIK3CA P42336 4/20 0.40
▸ MTOR P42345 2/20 0.40
▸ CREBBP Q92793 1/20 0.38
▸ GSK3B P49841 2/20 0.38
▸ DYRK1A Q13627 2/20 0.38
▸ ATM Q13315 1/20 0.37
▸ ATR Q13535 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ TTK P33981 3/20 0.37
▸ KDM1A O60341 1/20 0.36
▸ BMPR1A P36894 1/20 0.36
▸ ACVRL1 P37023 1/20 0.36
▸ ACVR1 Q04771 1/20 0.36
▸ PRKDC P78527 1/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ PI4KA P42356 1/20 0.35
▸ PIK3CG P48736 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31702313 0.92 DDB1 (0.51) DDB1CRBNPIK3CAMTORGSK3B
SCHEMBL23553708 0.87 DDB1 (0.56) DDB1CRBNPIK3CAMTORATM
SCHEMBL23540862 0.85 DDB1 (0.54) DDB1CRBNPIK3CAMTORGSK3B
SCHEMBL31701469 0.84 DDB1 (0.46) DDB1CRBNPIK3CAMTORPRKDC
SCHEMBL23540499 0.83 DDB1 (0.52) DDB1CRBNPIK3CAMTORATM
SCHEMBL31701616 0.83 DDB1 (0.48) DDB1CRBNPIK3CAMTORCREBBP
SCHEMBL23541274 0.81 DDB1 (0.49) DDB1CRBNPIK3CAMTORGSK3B
SCHEMBL31218927 0.80 CRBN (0.51) DDB1CRBN
SCHEMBL31702278 0.80 DDB1 (0.50) DDB1CRBNPIK3CAMTORGSK3B
SCHEMBL23540550 0.79 DDB1 (0.48) DDB1CRBNPIK3CAMTORGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 — — US disclosed
US-20250320206-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 DDB1 3966/4885CRBN 1627/4885PIK3CA 2223/4885
US-20250320206-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 DDB1 3966/4885CRBN 1627/4885PIK3CA 2223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback